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and Stevens S Smith1,2Abstract
Background: We report results of a pilot study designed to test a novel smoking cessation intervention,
Mindfulness Training for Smokers (MTS), in smokers age 18-29 years with regular episodes of binge drinking.
Mindfulness is a cognitive skill of applying close moment-to-moment attention to experience with a mental
posture of acceptance and non-reactivity. The MTS intervention consisted of six weekly classes that provided
instruction on how to use mindfulness to manage known precursors of smoking relapse including smoking
triggers, strong emotions, stressful situations, addictive thoughts, urges, and withdrawal symptoms.
Methods: The MTS intervention was compared to Interactive Learning for Smokers (ILS), a time/intensity matched
control group using daily non-directed walking instead of mindfulness meditation. Recruitment was conducted
primarily at local technical colleges. Primary outcome measures included biochemically-confirmed smoking
abstinence and reduction in alcohol use at the end of treatment (2-weeks post-quit attempt).
Results: The sample (N = 55) was 70.9% male, with a mean age of 21.9 years, and a mean of 11.76 alcoholic drinks
consumed per week. Intent-to-treat analysis showed biochemically-confirmed 7-day point prevalence abstinence
rates at 2-weeks post-quit for MTS = 20.0% and ILS = 4.0%, p = .08. Secondary analysis showed number of drinks per
week in the first 2-weeks post-quit correlated with smoking relapse at 2-weeks post-quit (p < .01).
Conclusions: This pilot study demonstrated that Mindfulness Training for Smokers shows promise for smoking
cessation and alcohol use reduction in treating young adult smokers with alcohol abuse. Results suggest the need
for a study with larger sample size and methods that reduce attrition.
Trial registration: ClnicalTrial.gov, NCT01679236
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Smoking is the leading preventable cause of morbidity
and mortality in the United States, causing 443,000
deaths and national costs of $96 billion each year [1],
with 23.1% of men and 18.1% of women self-identified
as cigarette smokers [2]. Smoking rates are highest in
young adults, with a 2010 survey showing that 35.8% of
21–25 year old US adults smoked at least once in the
past 30 days [3]. Young adults are uniquely susceptible
to social and peer group influences leading to substance* Correspondence: jjamesdavis@hotmail.com
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reproduction in any medium, provided the oruse and smoking [4]. The majority of smokers (88%)
begin smoking before the age of 18, and 99% of smokers
begin smoking before the age of 26 [5]. Tobacco com-
panies take advantage of the experimental processes in-
herent in young adult development by targeting young
people through advertising [6-8]. Many of the chronic
diseases associated with smoking are more common
among those who start smoking early in life [9-11], and
smoking cessation early in life provides the greatest
benefit in terms of reduced morbidity and mortality [12].
There has been a considerable effort toward reduction
of tobacco use through development of smoking ces-
sation medications [13], behavioral interventions [14],
passage of public smoking bans [15], mass media cam-
paigns [16], and government smoking bans [17,18].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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velopment of interventions targeted to young adult
smokers [19,20]. Over the last 50 years, there have been
only a small number of studies published on smoking in-
terventions targeted to young adults [21]. These include
a 1972 study in which male undergraduate smokers were
exposed to 24 hours of sensory deprivation as a smoking
cessation therapy [22], a 1988 study that compared a
brief counseling intervention vs. no intervention [23], a
1990 study that evaluated a behavioral therapy in under-
graduate smokers [24], and a 2007 study that applied a
brief office intervention vs. the same plus expressive
writing in young adult smokers [25]. Currently, the ma-
jority of young adult smokers attempt smoking cessation
without the help of medications or a smoking cessation
program [26] and achieve long-term abstinence rates of
less than five percent [27]. A barrier to development of
interventions targeting young adult smokers is that this
population is known to have high attrition in study pro-
tocols and poor adherence to behavioral therapies
[28,29]. The prospect of poor study outcomes with this
population may lead researchers to study treatments in
more compliant adult populations.
Young adult smokers face unique challenges in achiev-
ing smoking abstinence and accordingly, smoking cessa-
tion programs designed for young smokers must develop
unique strategies to overcome those challenges. One of
the most widely described challenges to young adult
smokers is the high prevalence of binge drinking and the
difficulties of maintaining abstinence during binge drink-
ing [3,30-34]. Binge drinking has been defined as con-
suming four or more alcoholic drinks on one or more
occasion for women and five or more drinks on one or
more occasion for men [35]. The National Survey on
Drug Use and Health (NSDUH) found that 40.6% of
young adults, ages 18–25 years, had at least one binge
drinking episode in the past 30 days [3]. Alcohol con-
sumption has been shown to increase the intensity of
smoking urges [36,37] and predict subsequent smoking
urges [38,39]. One study showed that subjects who en-
gaged in binge drinking were more likely to have smok-
ing relapse within the first year and to smoke more
cigarettes after relapse occurred [40]. Another study
showed that the probability of smoking relapse on heavy
drinking days was significantly higher than smoking on
moderate drinking or abstinent days [41]. There is now
a growing body of evidence to suggest that simultaneous
treatment of smoking and alcohol abuse leads to higher
rates of abstinence in both [42-45], and there is growing
interest in providing treatment for alcohol and tobacco
use concurrently [46,47]. Nonetheless, a recent literature
review using PubMed and PsycINFO revealed only one
published study on the treatment of smoking cessation
and binge drinking in young adults. In this study 41smoking binge drinkers age 18–30 years were random-
ized to receive either medications and semi-structured
smoking cessation counseling, or the same but with a
brief alcohol intervention. This study showed promising
effect sizes between groups favoring the dual treatment
arm, but was not powered to reach statistical signifi-
cance [46]. Cognitive-behavioral therapies (CBT) and
acceptance and commitment therapies (ACT) have
shown success in the treatment of alcohol abuse [47,48]
and smoking [49]. Recent studies suggest that mindful-
ness training, which has similarities with ACT, also
shows promise for alcohol abuse and smoking [50-53].
Research on Mindfulness Based Relapse Prevention
(MBRP) has demonstrated preliminary evidence for effi-
cacy in the treatment of alcohol dependence [54,55]. A
pilot study on mindfulness training in smokers found a
56% rate of abstinence at 6-weeks post-quit [56] and a
trial comparing a mindfulness-training program to an
active control found that mindfulness training yielded
significantly higher smoking abstinence at 17-weeks
post-quit [57].
The current study was designed to test a mindfulness
intervention, “Mindfulness Training for Smokers” (MTS),
that was developed as a treatment for smoking cessation.
The goal in this study was to teach mindfulness skills
targeted to smoking addiction and then see if the mindful-
ness skills obtained might generalize to decrease alcohol
use. The study employed NIH-endorsed research methods
for a stage-1 behavioral therapy program development
[58] with identified outcomes of exploring treatment ac-
ceptability and adherence and establishing initial efficacy
estimates necessary to guide future research. MTS was
designed to be intensive enough to activate core mindful-
ness insights of a Mindfulness Based Stress Reduction
(MBSR)-style course [59], but also include training on
how to use mindfulness to more skillfully manage relapse
challenges related to smoking triggers, social situations,
strong emotions, stressful situations, relapse-related
thoughts, urges and withdrawal symptoms. A similar
name “Mindfulness Training for Smoking Cessation”
has been used to describe another recently published
smoking cessation intervention with different structure
developed by Brewer [57]. The two interventions were
developed concurrently, and because materials
were already in use at the time of Brewer’s publication,
we continued to describe this program, as “Mindfulness
Training for Smokers.” Early assessment of participant
population (students from small towns around the
state) revealed that they would be unable to attend
long-term follow up visits. For this reason, the study
assessed outcomes only at the end-of-treatment, i.e.,
two weeks after the quit day. Primary outcomes were
defined as smoking abstinence confirmed via carbon
monoxide (CO) breath testing with daily smoking
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Recruitment took place in the Madison, Wisconsin area
and was conducted primarily through flyers and “one-
minute classroom presentations” at local community
colleges. Callers were provided with a brief description
of the study, and if interested, underwent phone screen-
ing. Inclusion criteria required that participants be 18 to
29 years old, smoke 10 or more cigarettes per day, and
report 5 or more alcohol “binges” per month. A binge
was defined as 5 or more drinks per day for males and 4
or more drinks for females [35]. Participants were ex-
cluded for possible alcohol dependence if they reported
drinking 4 or more drinks on 6 or more nights per week.
Participants were also excluded if they self-reported a
diagnosis of schizophrenia, bipolar or delusional dis-
order. Those who passed phone screening were invited
to attend an orientation session. Those who attended an
orientation session were excluded if carbon monoxide
(CO) breath testing showed a CO level of 10 parts per mil-
lion (ppm) or less. The orientation then included a de-
scription of the study, after which interested individualsAssessed for e
Declined during Screening (n = 29)
5 couldn’t make the schedule 
5 did not live in Madison 
4 did not drink alcohol 
3 already quit 
2 were not interested 















Treatment Completers (n = 15) (50%)







Figure 1 Consort diagram.signed the consent form and completed baseline testing.
Subjects were then randomized into either Mindfulness
Training for Smokers (MTS) or the control condition
“Interactive Learning for Smokers” (ILS) by random draws.
Descriptions of the two interventions and other processes
were provided in such a way so as to decrease the possibil-
ity that controls might know that they had been random-
ized to a control arm. Phone screening was conducted on
468 callers leading to 215 callers scheduled for orienta-
tions. The main reason for exclusion was insufficient alco-
hol use (less than 5 binges per month). Of scheduled
callers, 74 (34%) attended an orientation, after which 55
were randomized to MTS (n = 30) or ILS (n = 25). Among
these 55 participants, a total of 25 (45%) completed treat-
ment (attended Quit Day Retreat) and testing (two-weeks
post-quit assessment visit), including 15 MTS participants
and 10 ILS participants (Figure 1). This study was carried
out in compliance with the guidelines provided by the
Helsinki Declaration, and was approved and overseen by
the University of Wisconsin-Madison Health Sciences In-
ternal Review Board (H-2006-0279).
Measurements
Study assessment visits were performed at baseline and
at the end of treatment (two weeks after the Quit Dayligibility (n = 468)
Excluded during Screening (n = 214)
145 did not consume enough alcohol 
34 smoked less than 5 cigs/day
17 excluded due to psychosis 
6 excluded due to personality disorder 
3 were under the age of 18 
10 were over the age of 29
ientation (n = 215)
ientation (n = 74)
Treatment Completers (n = 10) (40%)
ILS Enrollment (n = 25) (45%)
ized (n = 55)
Excluded for CO < 10 (n = 19)
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collection:
1) Tobacco and alcohol use. Two metrics were used to
assess post-quit day smoking behavior: a self-report
testing via “timeline followback” (TLFB) calendar
[60-62], and biomedical testing via carbon monoxide
(CO) breath testing. Participants were asked to log
cigarette consumption via TLFB each day
throughout the intervention until 2 weeks after the
quit day. For CO breath testing, the study utilized
the Micro + ™ Smokerlyzer® and employed a more
stringent CO cutoff of 7 ppm (instead of 10 ppm) to
reduce the chance of false positives for a coding of
abstinent [63]. Failure to provide self-report of no
cigarette consumption during the seven days prior
to the post-quit assessment visit, or to provide a CO
reading of under 7.0 ppm on the breath test, or to
attend an assessment visit all resulted in coding as
“relapsed”. A contemporary measure “number of
days smoked in the first two weeks post-quit” has
been shown to correlate well with 6-month smoking
cessation outcomes [64], and was used to provide a
continuous measure of smoking abstinence. Daily
alcohol use was also assessed using TLFB, wherein
participants recorded the number of alcoholic drinks
that they consumed each day throughout the
intervention until two weeks after the quit day.
Biochemical confirmation was not used to assess
alcohol consumption.
2) Demographics and substance use. A non-validated
baseline questionnaire was provided to participants
to assess demographic characteristics and substance
use history. In addition to demographic information,
this questionnaire included questions such as “How
many years have you smoked cigarettes?” and “In
the last seven days, how many days did you drink
alcohol?”
3) Intervention completion. Completion of either
intervention was defined via attendance record as
attendance at the Quit Day Retreat. This criterion
was used because it provided confirmation that a
quit attempt was made and because it reflected
overall class attendance. For example, all
participants who attended four or more classes also
attended the Quit Day Retreat, and all who
attended one or fewer classes did not attend the
Quit Day Retreat”
4) Practice compliance. Compliance with daily
meditation practice was assessed via telephone calls
made to participants, during which they were asked
how many minutes they had practiced meditation
in the past 24 hours. Calls were made once a day
for 5 days prior to the beginning of treatment andonce a day for 5 days after the quit day. “Minutes
meditated” was averaged across the five calls in
each time period, yielding an average number of
minutes meditated per day.
5) Nicotine dependence. The Fagerstrom Test for
Nicotine Dependence (FTND) [65] was administered
at baseline to assess nicotine dependence. The
FTND is a widely used six-item measure designed to
determine the extent to which an individual has
developed dependence on nicotine. The measure
possesses fair internal consistency (α = .61) and
correlates well with biological indices of heaviness of
smoking [65]. Example questions include “How soon
after you wake up do you smoke your first
cigarette?” and “How many cigarettes do you smoke
per day?”
6) Smoking motives. Motivation for smoking was
assessed via the Brief Wisconsin Inventory of
Smoking Dependence Motives (WISDM) completed
at baseline [66]. The Brief WISDM is a 37-item
subset of the original 68-item WISDM
questionnaire, loads onto 11 motivational subscales,
and has acceptable internal consistency (α = .69).
The instrument provides items such as, “Smoking
really helps me feel better if I’ve been feeling down,”
and uses a 7-point Likert scale ranging from 1 = “not
at all true of me” to 7 = “extremely true of me” [66].
7) Mindfulness. To assess mindfulness, the Frieburg
Mindfulness Inventory (FMI) [67] was administered
at the baseline and post-quit assessment visits to
assess the potential acquisition of mindfulness skills
as a result of the mindfulness or control
intervention. Example items include “I pay attention
to what’s behind my actions” and “I am open to the
experience of the present moment,” and use a 4-
point Likert scale with 1 = “rarely” and 4 = “almost
always” as possible responses. The shorter 14-item
FMI was used and has demonstrated acceptable
internal consistency (α = .86) [67].
8) Distress tolerance. The Distress Tolerance Scale
(DTS) was administered at baseline and two-week
post-quit assessment visit to assess how participants
tolerated, appraised, absorbed and regulated their
distress [68]. The DTS is a 14-item questionnaire,
with acceptable internal consistency (α = .89),
includes items such as “I can’t handle feeling
distressed or upset,” with possible responses on a 5
point Likert scale ranging from 1 = “strongly agree”
to 5 = “strongly disagree” [68].
9) Stress. The Perceived Stress Scale-10 (PSS) was
provided to participants at baseline and at the two-
week post-quit assessment visit [69]. The PSS is
designed to assess affective reactions to stressors; it
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provides questions such as “In the last month, how
often have you felt that you were unable to control
the important things in your life?” and allows for
responses on a 5-point Likert scale with 0 = “never”
and 4 = “very often” [69].
10)Course Acceptability: A non-validated course
evaluation was administered at the 2-week post-quit
assessment visit. The instrument included questions
for the purpose of assessing use of materials,
adherence to practices, and accessibility of various
instructions. An example item was “Meditation/
Walking has helped me manage cravings” and provided
a 7-point Likert scale response from 1 = “completely
disagree” to 7 = “completely agree”. The instrument
also included four written-answer questions to obtain
more open-ended feedback on what was most or least
helpful in the interventions.Procedure
MTS and ILS interventions lasted six weeks with identi-
cal schedules consisting of six 2-hour weekly classes plus
a 7-hour Quit Day Retreat on the weekend between clas-
ses four and five. Each class was comprised of 45 minutes
of instruction, 45 minutes of group discussion, and
30 minutes of meditation (MTS), or silent, non-directed
walking (ILS) (Table 1). MTS participants were asked to
practice 30 minutes of meditation per day with a guided
meditation CD, whereas ILS participants were asked to
practice non-directed walking (walking silently and alone
without music or a goal destination) for 30 minutes each
day. Instructors for both MTS and ILS held Master’s de-
grees in psychology and had equivalent experience with
smoking cessation interventions. Participants in each
group received a 50-page manual containing the core
material in the intervention written to approximately a
ninth grade reading level. Neither MTS nor ILS treat-
ments provided instruction targeted to alcohol abuse. At
the Quit Day Retreat, participants in each group wereble 1 MTS and ILS participant activities
ass MTS
1 Mindfulness Meditation, Body Scan
2 Mindfulness and Emotions
3 Mindfulness and Smoking Triggers
4 Mindfulness for Urges
5 Quit Day–Mindfulness Practices
6 Mindfulness and Withdrawal
7 Long Term Meditation Practice
2-week post-quit assessment visit
e Quit Day Retreat was a 7-hour silent retreat with instructor-guided mindfulness
ch class incorporated a 30-minute guided meditation and 45 minutes of supportasked to attempt smoking cessation and stop drinking
alcohol for one month. Participants were provided with
no medications, and the use of smoking or alcohol
cessation medications was discouraged. The Quit Day
Retreat provided seven hours of instructor-guided mind-
fulness practice for MTS participants and seven hours of
instructor-guided non-directed walking and group inter-
action for ILS. After the Quit Day Retreat, participants
were asked to attend two additional classes, which pro-
vided no additional skills training, but provided a forum
for group interaction and discussion.Control intervention
The Interactive Learning for Smokers (ILS) intervention
combined elements of the American Lung Association’s
Freedom from Smoking program [70] and The Mayo
Clinic’s Nicotine Dependence Center program [71] and was
constructed to help participants develop individualized
smoking cessation strategies to manage relapse challenges
related to smoking triggers, social situations, strong emo-
tions, stressful situations, relapse-related thoughts, urges
and withdrawal symptoms–areas also targeted in MTS. ILS
participants were asked to practice thirty minutes of silent
non-directed walking per day throughout the intervention,
and to further match MTS, were instructed to use non-
directed walking for relaxation, stress reduction and as a
strategy for managing urges and withdrawal symptoms.Data analysis
Management of missing data followed recommended
methods [72]. Assessment of the primary abstinence and
alcohol outcome variables included intent-to-treat analysis
as well as analysis of intervention completers. For intent-
to-treat analyses, failure to attend the assessment visits
resulted in coding the participant as relapsed with return
to pre-intervention alcohol use or tobacco use (i.e.,
missing = smoking). Independent groups t-tests and
chi-square tests were conducted to compare baseline
characteristics between groups. Logistic regression wasILS
Stages of Change, Motivation to Quit
Physical + Psychological Addiction, Your Addiction
Smoking and the Body, Managing Triggers




2-week post-quit assessment visit
practices.
group interaction as “mindful talking and listening”.
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ence and to compute odds ratios (OR) estimates and
confidence intervals. ANOVAs were used to evaluate
repeated measures (continuous variables) over time.
Pearson correlations were computed to identify associa-
tions between secondary outcome measures and con-
tinuous smoking outcomes. Analyses were performed
using SPSS, Version XX.
Results
Participant mean age was 21.9 years (SD = 2.53), 70.9%
male, and 83% white (Table 2). Baseline testing showed
no statistically significant differences between MTS and
ILS groups on gender, race, ethnicity, age, number of
cigarettes smoked per day, or average number of drinks
per day.
Intent-to-treat chi-square analysis showed that bio-
chemically confirmed 7-day point prevalence smoking
abstinence rates at 2-weeks was higher for MTS than
ILS, but the finding was not significant (p = .08) (Table 3).
Similarly, intervention completers demonstrated higher
7-day point prevalent abstinence rates in MTS compared
to ILS, but the finding was not significant (p = .10). Inde-
pendent t-test showed that MTS had a significantly
greater number of days of smoking abstinence in the
first two weeks compared to ILS in both intent-to-treat
analysis and analysis of completers.
Completer post-quit analysis using independent t-test
showed no significant differences between number of
drinks per week in MTS (M = 10.70, SD = 11.94) and ILSTable 2 Participant baseline characteristics





Male 70.9% 70.0% 72.0% .87
Female 29.1% 30.0% 18.0%
Race
American Indian 1.8% 3.3% 0.0% .37
Asian 0.0% 0.0% 0.0% N/A
African American 1.8% 0.0% 4.0% .33
Latino/Hispanic* 5.5% 6.7% 4.0% .67
White 90.9% 90.0% 92.0% .82
Other 0.0% 0.0% 0.0% N/A
Age 21.93 (2.53) 21.70 (2.42) 22.20 (2.68) .47
Number of
cigarettes/day
13.75 (6.36) 13.63 (3.90) 13.88 (8.52) .89
Number of drinks
per week**
11.76 (8.36) 12.73 (9.92) 10.30 (5.42) .49
* Recruitment materials were in English and did not target non-English
speaking populations.
** Data collected from completers only from course evaluations (n = 25).(M = 15.25, SD = 8.08), t(23) = 1.05, p = .30. Completer
analysis showed that ILS significantly increased drinks
per week from pre-quit (M = 10.30, SD = 5.42) to post-
quit (M = 15.25, SD = 8.08), t(9) = −2.60, p = .03, whereas
MTS decreased drinks per week from pre-quit (M =
12.73, SD = 9.92) to post-quit (M = 10.70, SD = 11.94), al-
though the difference was not significant, t(14) = .59,
p = .56. There was not a significant interaction between
treatment groups and drinks per week over time, F(1,
23) = 2.41, p = .14.
Analyses were conducted to determine whether post-
quit alcohol consumption was correlated with smoking
relapse. Findings showed that among intervention com-
pleters, participants who had maintained smoking absti
nence at two-weeks post-quit (n = 7) reported significantly
fewer days drinking alcohol (M= 2.43, SD = 1.90) than
participants who were smoking relapsed (n = 18) (M =
4.72, SD = 2.67), t(23) = 2.06, p = .05. Total number of
drinks per week post-quit showed a similar pattern, with
smoking abstinent participants drinking only 5.0 (SD =
6.64) drinks per week vs. smoking relapsed participants
showing 15.44 (SD = 10.56) drinks per week, t(23) = 2.42,
p = 0.02). Number of drinks per week post-quit was sig-
nificantly negatively correlated with smoking relapse,
r(25) = −.38, p < .05.
Attrition for all participants from randomization to as-
sessment visit was 55% with no significant difference be-
tween groups (MTS = 50.0%, ILS Controls = 60.0%), χ2(1,
N = 55) = 0.55, p = .46. We found no predictors for attri-
tion, including age, gender, FTND, FMI, DTS, or PSS or
WISDM. When comparing those who attended the two-
week post-quit assessment visit (completers) to those
who did not (non-completers) on baseline variables, we
found no significant differences between intervention
randomization, gender, ethnicity, age, FTND, FMI, DTS,
PSS, or WISDM (Table 4), but did find that completers
reported smoking fewer cigarettes per day at baseline
(M = 11.88, SD = 3.00) than non-completers (M = 15.30,
SD = 7.89), t(53) = 2.19, p = .04. Participants who had
dropped out or missed classes showed that technical col-
lege exams and vacations accounted for the majority of
attrition. There was no significant difference in class at-
tendance for intervention completers: 80.3% for MTS
and 75.0% for ILS, p = .44. Mean minutes per day medi-
tating/walking was assessed in course completers and
showed means for MTS of 24.41 minutes meditation,
and ILS of 46.81 minutes walking (30 min/day requested
for each), p = .17. Acceptability of the manual was mixed
in that almost all completers claimed to have read sec-
tions of the manual but only two participants in ILS and
three in MTS claimed to have read the entire manual.
The primary reason cited for not reading the manual
was that most participants did not commonly read
books voluntarily.
Table 3 Smoking outcomes
Analysis MTS (SD) ILS (SD) χ2 t β Odds Ratio (CI) Wald p-value
Intent-to-Treat (n = 55) 2-week point prevalence abstinence 20.0% (.41) 4.0% (.20) 3.14 N/A 1.79 6.00 (.67-53.68) 2.57 .08
Completers (n = 25) 2-week point prevalence abstinence 40.0% (.51) 10.0% (.32) 2.68 N/A 1.79 6.00 (.60-60.44) 2.31 .10
Intent-to-Treat (n = 55) Days abstinent two-weeks post-quit 5.10 (6.00) 2.04 (3.98) N/A 2.26 N/A N/A N/A .03*
Completers (n = 25) Days abstinent two-weeks post-quit 10.20 (4.36) 5.10 (5.00) N/A 2.71 N/A N/A N/A .01*
*statistically significant.
χ2 - chi-square statistic, t - independent samples t-test statistic, β - Beta coefficient, CI - confidence interval.
For those who did not attend follow-up in intent-to-treat analysis, participants were recorded as smoking every day.
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This pilot study was designed to investigate the potential
usefulness of a mindfulness-based therapy in young
adult smokers with binge alcohol use. This is of particu-
lar interest because of the high prevalence of alcohol use
in this age group and the strong relationship between
alcohol use and smoking relapse. The study was designed
to compare a mindfulness-based intervention to a closely-
matched active control. There was no therapy targeted to
alcohol use provided to either group, and it was hoped
that mindfulness training might have generalized effects
on alcohol use. The population was primarily young malesTable 4 Completer vs. non-completer baseline comparison
Total (SD) Attended follow-








American Indian 1.8% 4.0%
Asian 0.0% 0.0%




Ethnicity (Hispanic) 5.5% 8.0%
Age 21.93 (2.53) 22.00 (2.33)
Number of cigarettes/day 13.75 (6.36) 11.88 (3.00)
FTND 3.25 (1.70) 3.39 (1.59)
FMI 27.71 (6.31) 29.43 (5.98)
DTS 3.46 (.90) 3.55 (.90)
PSS 17.78 (7.02) 15.91 (6.13)
WISDM 53.26 (9.31) 53.06 (7.94)
*Statistically significant.
**Recruitment materials were in English only.in their twenties who engaged in regular heavy binge
drinking. Major findings from the study were the follow-
ing: 1) Smoking abstinence: In our primary outcome, point
prevalent smoking abstinence was higher in MTS than
controls, but the difference was not significant. As a sec-
ondary outcome, MTS compared to ILS participants
showed significantly greater number of days abstinent in
the first two weeks. 2) Alcohol use: Controls significantly
increased alcohol consumption over the course of their
intervention whereas MTS participants decreased con-
sumption, but not significantly. 3) Alcohol use and




















Davis et al. BMC Complementary and Alternative Medicine 2013, 13:215 Page 8 of 10
http://www.biomedcentral.com/1472-6882/13/215associated with smoking relapse in every measure
obtained; 4) Attrition: Attrition was high for both
groups; and 5) Acceptability: Class attendance was rea-
sonable for completers; minutes meditated and minutes
walked were also reasonably high for completers.
Although this was a pilot study and was underpowered
to provide statistically significant differences on many
outcomes, the study still yielded some meaningful find-
ings. It is noteworthy that ILS yielded such low smoking
cessation rates (4%) although it was an intense interven-
tion, with skilled instructors, group support, skills train-
ing, and cognitive behavioral strategies used in evidence-
based programs. These low rates make a compelling case
that the sample population is an intrinsically challenging
group. The modestly higher smoking cessation rates for
the MTS intervention (10%) are only noteworthy within
the context of understanding the challenges of treating
this population. It was further encouraging that number
of days smoked in the first two weeks was in fact signifi-
cantly less for MTS than ILS. The fact that mindfulness
training made any difference at all in these densely-
layered intensive interventions [73] is surprising, and
suggests the possibility that mindfulness training may
have had an independent therapeutic effect on smoking.
Alcohol outcomes need to be understood in the con-
text of the fact that this population was young, mostly
male, drank heavily, and that neither intervention pro-
vided alcohol-specific treatment. The hope was that
skills learned from MTS might have generalized to re-
duce alcohol use. Surprisingly, this study showed that
controls significantly increased their alcohol use after
the quit day, whereas MTS participants showed a de-
crease that was non-significant. A possible explanation
of this data is that smoking cessation is stressful and
might lead to a greater tendency to drink (as seen in
ILS), and that mindfulness training attenuated this ten-
dency to drink more post-quit. The findings of this pilot
study were not powered sufficiently to demonstrate that
mindfulness is an effective simultaneous treatment of
comorbid alcohol and tobacco abuse. Given, however,
the growing support for simultaneous treatment of both
alcohol and tobacco [42-44,46,74,75], and the fact there
are already mindfulness-based therapies for the treat-
ment of alcohol [54,55] and tobacco [57,73], the findings
suggest that there may be promise for larger studies on
mindfulness training for both alcohol and tobacco use.
An expected finding in this study was the association
between alcohol use and smoking relapse. Participants
who were smoking abstinent compared to relapsed
drank significantly fewer days post-quit and showed a
significant correlation between abstinence and alcohol
use. This is consistent with studies on older populations
that show that binge drinking [40] and moderate drink-
ing [41] are correlated with smoking relapse. The findingof a significant correlation in a study with small sample
size suggests that the strong relationship between alco-
hol use and smoking relapse also exists in the young
adult population. Findings suggest that it might be bene-
ficial for investigators to further study the relationship of
alcohol and tobacco in the young adult population.
Participants who completed the intervention provided
relatively positive comments about both MTS and ILS.
Among course evaluations, both groups cited group sup-
port and instructor support as most important, and each
group mentioned meditation (or non-directed walking)
as helpful to them. Written reports about the experience
of meditation were very positive and suggested that
these individuals, though young and prone to high-risk
behavior, were also capable of quiet reflection. The use
of the manuals was disappointing in both groups, with
most participants reading only small portions. When
asked why they did not read the manuals, the most com-
mon answer was that participants did not normally
engage in voluntary reading. This suggests that interven-
tion information might be better provided in another
form such as video.
A major limitation in this study was high attrition in
every phase–recruitment, retention and follow-up. High
attrition rates were first noted during recruitment when
only 34% of callers scheduled for an orientation actually
attended an orientation. This suggests that this popula-
tion had high non-compliance before initiation of any
intervention. Intervention attrition rates were also simi-
larly high in both groups.
One possible conclusion regarding attrition in this
study is that young adult smokers are not very interested
in intensive therapies such as those offered. Previous
studies on young adult smoker have also shown high at-
trition in study protocols and poor adherence to behav-
ioral therapies [28,29]. This may be true for many such
individuals; however, reports from those who completed
the intervention were very positive, suggesting that for a
portion of participants the interventions showed good
acceptability. It is likely that the completer analyses is
reporting results on those participants who were most
receptive to mindfulness training, artificially increasing
effect sizes. In the future trials on young adult binge
drinkers, it would be wise to incorporate design ele-
ments to decrease attrition. Such methods might in-
clude identification of individuals that are most prone to
stay in an intensive intervention, or implementation of
incentives for treatment adherence. Another limitation
of this study was small sample size. As a pilot study, the
sample size was such that even if respectable differ-
ences were found between groups, smoking and alco-
hol outcomes would likely be underpowered to reach
significance. A final study limitation is that outcomes
were assessed only at 2-weeks post-quit and, as such,
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ferences at long-term follow-up (e.g., 6-months post-
quit) are unknown.
Conclusions
This study was designed as part of a mindfulness in-
tervention development effort consistent with NIH-
endorsed stage-1 development protocols for testing
emerging therapies. Goals of this type of pilot study
were to provide understandings of program accep-
tability, estimates of effect sizes, and insights to guide
program development [58]. Primary findings from this
study suggest that MTS, compared to a closely matched
control, produced non-significant increases in short-term
(2-week) smoking abstinence and showed reasonable ac-
ceptability among those who completed the interven-
tion. The study also showed non-significant differences
in alcohol use in MTS compared to controls. This sug-
gests some promise that mindfulness skills, taught for
the purpose of smoking cessation, may generalize to de-
crease alcohol use. It is hoped that these findings might
be useful in the design of future studies that evaluate
mindfulness-based treatments for smokers.
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